| 1 | Zollinger-Ellison syndrome | 61.6% |
| 2 | Intestinal Neoplasms | 57% |
| 3 | Esophageal Neoplasms | 54% |
| 4 | Colorectal Neoplasms | 47.3% |
| 5 | Cecal Neoplasms | 45% |
| 6 | Duodenal Neoplasms | 45% |
| 7 | Gastritis | 39.8% |
| 8 | Gastrointestinal Stromal Tumors | 38.7% |
| 9 | Appendiceal Neoplasms | 37.2% |
| 10 | Colonic Neoplasms | 37.2% |
| 11 | Rectal Neoplasms | 37.2% |
| 12 | Duodenogastric Reflux | 35.7% |
| 13 | Peptic Ulcer | 35.7% |
| 14 | Anus Neoplasms | 35.6% |
| 15 | Sigmoid Neoplasms | 35.6% |
| 16 | Proctocolitis | 34.1% |
| 17 | Liver neoplasms | 33.3% |
| 18 | Peritoneal Neoplasms | 32.9% |
| 19 | Adenomatous Polyposis Coli | 32.9% |
| 20 | Dysentery | 30.9% |
| 21 | Enteritis | 30.9% |
| 22 | Enterocolitis | 30.9% |
| 23 | Esophagitis | 30.9% |
| 24 | Inflammatory Bowel Diseases | 30.9% |
| 25 | Duodenitis | 29.4% |
| 26 | Ileitis | 29.4% |
| 27 | Erosive Duodenitis | 29.4% |
| 28 | Pancreatic Neoplasm | 29.4% |
| 29 | Gastric Dilatation | 29.1% |
| 30 | Gastric outlet obstruction | 29.1% |
| 31 | Esophageal Diseases | 28.2% |
| 32 | Gastroenteritis | 28.2% |
| 33 | Intestinal Diseases | 28.2% |
| 34 | Duodenal Ulcer | 27.5% |
| 35 | Peptic Ulcer Perforation | 27.5% |
| 36 | Gastric ulcer | 27.5% |
| 37 | Colitis | 26.9% |
| 38 | Proctitis | 26.9% |
| 39 | Pouchitis | 24.4% |
| 40 | Achlorhydria | 24.3% |
| 41 | Gastric Antral Vascular Ectasia | 24.3% |
| 42 | Gastroparesis | 24.2% |
| 43 | Bile Duct Neoplasms | 24% |
| 44 | gallbladder neoplasm | 24% |
| 45 | Gastrointestinal Hemorrhage | 23.5% |
| 46 | Tuberculosis, Gastrointestinal | 23.2% |
| 47 | Appendicitis | 23.1% |
| 48 | Crohn Disease | 23% |
| 49 | Duodenal Obstruction | 23% |
| 50 | Enterocolitis, Neutropenic | 23% |
| 51 | Necrotizing Enterocolitis | 23% |
| 52 | Mesenteric vascular insufficiency | 22.2% |
| 53 | Esophageal and Gastric Varices | 22.1% |
| 54 | Rectal Fistula | 22.1% |
| 55 | Anal Fistula | 22.1% |
| 56 | Esophageal Atresia | 22% |
| 57 | Intestinal Atresia | 22% |
| 58 | Mesenteric Vascular Occlusion | 22% |
| 59 | Intestinal Fistula | 21.9% |
| 60 | Enterocutaneous Fistula | 21.9% |
| 61 | Pyloric Stenosis | 21.7% |
| 62 | Biliary Tract Diseases | 20.7% |
| 63 | Liver diseases | 20.7% |
| 64 | Pancreatic Diseases | 20.7% |
| 65 | Hepatocellular Adenoma | 19.8% |
| 66 | Enterocolitis, Pseudomembranous | 19.6% |
| 67 | pseudomembranous colitis | 19.6% |
| 68 | Dysentery, Bacillary | 19.6% |
| 69 | Liver Neoplasms, Experimental | 18.8% |
| 70 | Cecal Diseases | 18.5% |
| 71 | Colonic Diseases | 18.5% |
| 72 | Esophageal Stenosis | 18.5% |
| 73 | Ileal Diseases | 18.5% |
| 74 | Intestinal Obstruction | 18.5% |
| 75 | Intestinal Perforation | 18.5% |
| 76 | Jejunal Diseases | 18.5% |
| 77 | Pneumatosis Cystoides Intestinalis | 18.5% |
| 78 | Rectal Diseases | 18.5% |
| 79 | Cronkhite-Canada Syndrome | 18.5% |
| 80 | Intestinal Polyposis | 18.5% |
| 81 | Barrett Esophagus | 18.4% |
| 82 | Colitis, Ischemic | 18.2% |
| 83 | Colonic Pseudo-Obstruction | 18% |
| 84 | Dumping Syndrome | 18% |
| 85 | Gastrointestinal Neoplasms | 17.4% |
| 86 | Pancreatic Fistula | 17.3% |
| 87 | Stomach Neoplasms | 16.5% |
| 88 | Carcinoma, Pancreatic Ductal | 16.3% |
| 89 | Stomach Diseases | 16.1% |
| 90 | Esophageal Perforation | 16% |
| 91 | Intestinal Diseases, Parasitic | 16% |
| 92 | Deglutition Disorders | 15.6% |
| 93 | Peptic Ulcer Hemorrhage | 15.4% |
| 94 | Biliary cirrhosis | 14.8% |
| 95 | Choledochal Cyst | 14.8% |
| 96 | Colonic Diseases, Functional | 13.8% |
| 97 | Esophageal motility disorders | 13.8% |
| 98 | Fecal Incontinence | 13.8% |
| 99 | Fecal Impaction | 13.8% |
| 100 | Intussusception | 13.8% |
| 101 | Mallory-Weiss Syndrome | 13.8% |
| 102 | Megacolon | 13.8% |
| 103 | Ileus | 13.8% |
| 104 | Meconium ileus | 13.8% |
| 105 | Melena | 13.3% |
| 106 | Cholecystolithiasis | 13.3% |
| 107 | Hematemesis | 13.1% |
| 108 | insulinoma | 13.1% |
| 109 | Gastrinoma | 13% |
| 110 | Glucagonoma | 13% |
| 111 | Pancreatic Cyst | 13% |
| 112 | Vipoma | 12.2% |
| 113 | Bile Duct Diseases | 12.1% |
| 114 | Cholelithiasis | 12.1% |
| 115 | Chylous Ascites | 12.1% |
| 116 | Fatty Liver | 12.1% |
| 117 | Hepatitis | 12.1% |
| 118 | Portal Hypertension | 12.1% |
| 119 | Liver Cirrhosis | 12.1% |
| 120 | Pancreatic Insufficiency | 12.1% |
| 121 | Pancreatitis | 12.1% |
| 122 | Pneumoperitoneum | 12.1% |
| 123 | Focal Nodular Hyperplasia | 12.1% |
| 124 | Hepatic Insufficiency | 12.1% |
| 125 | Steatohepatitis | 12.1% |
| 126 | Hemorrhoids | 11.7% |
| 127 | Digestive System Neoplasms | 11.6% |
| 128 | Afferent Loop Syndrome | 11.5% |
| 129 | Celiac Disease | 11.5% |
| 130 | Short Bowel Syndrome | 11.5% |
| 131 | Sprue, Tropical | 11.5% |
| 132 | Steatorrhea | 11.5% |
| 133 | Rectocele | 11.5% |
| 134 | Sprue | 11.5% |
| 135 | Choledocholithiasis | 11.5% |
| 136 | Diverticulitis | 11.5% |
| 137 | Esophageal Achalasia | 11.5% |
| 138 | Anal Fissure | 11.5% |
| 139 | Intestinal Pseudo-Obstruction | 11.5% |
| 140 | Irritable Bowel Syndrome | 11.5% |
| 141 | Rectal Prolapse | 11.5% |
| 142 | Superior Mesenteric Artery Syndrome | 11.5% |
| 143 | Neurogenic Bowel | 11.5% |
| 144 | Anal Ulcer | 11.5% |
| 145 | Fatty Liver, Alcoholic | 11.3% |
| 146 | Hepatitis, Alcoholic | 11.3% |
| 147 | Liver Cirrhosis, Alcoholic | 11.3% |
| 148 | Peutz-Jeghers Syndrome | 10.8% |
| 149 | Liver Diseases, Parasitic | 10.4% |
| 150 | Hepatic Veno-Occlusive Disease | 10.2% |
| 151 | Peliosis Hepatis | 10.2% |
| 152 | Hepatopulmonary Syndrome | 10.2% |
| 153 | Giardiasis | 10.1% |
| 154 | Abdominal Neoplasms | 10.1% |
| 155 | Head and Neck Neoplasms | 10.1% |
| 156 | Soft Tissue Neoplasms | 10.1% |
| 157 | Thoracic Neoplasms | 10.1% |
| 158 | Anus, Imperforate | 10.1% |
| 159 | Hemoperitoneum | 10.1% |
| 160 | Hepatomegaly | 10.1% |
| 161 | Mesenteric Panniculitis | 10.1% |
| 162 | Panniculitis, Peritoneal | 10.1% |
| 163 | Peritonitis | 10.1% |
| 164 | Peritoneal Fibrosis | 10.1% |
| 165 | Encapsulating Peritoneal Sclerosis | 10.1% |
| 166 | Anorectal Malformations | 10.1% |
| 167 | Biliary Fistula | 10% |
| 168 | Gastric Fistula | 10% |
| 169 | Hepatic Vein Thrombosis | 10% |
| 170 | Liver Abscess | 10% |
| 171 | Budd-Chiari Syndrome | 10% |
| 172 | Diverticulum | 10% |
| 173 | Diverticulosis | 10% |
| 174 | Pruritus Ani | 9.6% |
| 175 | Liver Abscess, Amebic | 8.9% |
| 176 | Chemical and Drug Induced Liver Injury | 8.8% |
| 177 | Laryngopharyngeal Reflux | 8.7% |
| 178 | Endocrine Gland Neoplasms | 8.7% |
| 179 | Eye Neoplasms | 8.7% |
| 180 | Nervous System Neoplasms | 8.7% |
| 181 | Lactose Intolerance | 8.6% |
| 182 | Hepatorenal Syndrome | 8.6% |
| 183 | Bone neoplasms | 8.5% |
| 184 | Skin Neoplasms | 8.5% |
| 185 | Hematologic Neoplasms | 8.5% |
| 186 | Splenic Neoplasms | 8.4% |
| 187 | Pancreatic Pseudocyst | 8.3% |
| 188 | Cholangitis | 7.9% |
| 189 | Cholecystitis | 7.9% |
| 190 | Cholestasis | 7.9% |
| 191 | Common Bile Duct Diseases | 7.9% |
| 192 | Hepatitis, Chronic | 7.9% |
| 193 | Liver Failure | 7.9% |
| 194 | Pancreatitis, Chronic | 7.9% |
| 195 | Non-alcoholic Fatty Liver Disease | 7.9% |
| 196 | Chronic active hepatitis | 7.9% |
| 197 | Cystic Fibrosis | 7.7% |
| 198 | Parathyroid Neoplasms | 7.6% |
| 199 | Thyroid Neoplasm | 7.6% |
| 200 | Thyroid carcinoma | 7.6% |
| 201 | Porphyrias, Hepatic | 7.5% |
| 202 | Congenital Hyperinsulinism | 7.5% |
| 203 | Multiple Endocrine Neoplasia | 7.2% |
| 204 | Cryptosporidiosis | 7% |
| 205 | Gastrointestinal Diseases | 6.9% |
| 206 | Hepatitis, Animal | 6.9% |
| 207 | Hepatitis, Viral, Human | 6.9% |
| 208 | Paraneoplastic Encephalomyelitis | 6.8% |
| 209 | Hepatitis B, Chronic | 6.7% |
| 210 | Hepatitis C, Chronic | 6.7% |
| 211 | Mammary Neoplasms, Experimental | 6.7% |
| 212 | Liver Cirrhosis, Experimental | 6.6% |
| 213 | Pancreatitis, Alcoholic | 6.6% |
| 214 | Tracheal Neoplasms | 6.3% |
| 215 | Hamartoma | 6.2% |
| 216 | Neoplasms, Hormone-Dependent | 6.2% |
| 217 | Neoplasms, Multiple Primary | 6.2% |
| 218 | Paraneoplastic Syndromes | 6.2% |
| 219 | Precancerous Conditions | 6.2% |
| 220 | Neoplasms, Second Primary | 6.2% |
| 221 | Acanthoma | 6% |
| 222 | Retroperitoneal Neoplasms | 6% |
| 223 | Cholestasis, Extrahepatic | 5.9% |
| 224 | Biliary Dyskinesia | 5.9% |
| 225 | Cholangitis, Sclerosing | 5.9% |
| 226 | Liver Failure, Acute | 5.9% |
| 227 | Acalculous Cholecystitis | 5.9% |
| 228 | End Stage Liver Disease | 5.9% |
| 229 | Fascioliasis | 5.7% |
| 230 | Echinococcosis, Hepatic | 5.7% |
| 231 | CREST Syndrome | 5.7% |
| 232 | Chemical and Drug Induced Liver Injury, Chronic | 5.7% |
| 233 | Reye Syndrome | 5.7% |
| 234 | Cyst | 5.2% |
| 235 | Neoplastic Processes | 5.2% |
| 236 | Neoplastic Syndromes, Hereditary | 5.2% |
| 237 | Pregnancy Complications, Neoplastic | 5.2% |
| 238 | Neoplasms, Experimental | 5.1% |
| 239 | Carcinoma, Lobular | 5.1% |
| 240 | Mouth Neoplasms | 5% |
| 241 | Central Nervous System Neoplasms | 5% |
| 242 | Vascular Neoplasms | 5% |
| 243 | Thymus Neoplasms | 5% |
| 244 | Testicular Neoplasms | 5% |
| 245 | Autoimmune hepatitis | 5% |
| 246 | Genital Neoplasms, Female | 5% |
| 247 | Breast Neoplasms, Male | 4.9% |
| 248 | Triple Negative Breast Neoplasms | 4.9% |
| 249 | Thyroid Nodule | 4.9% |
| 250 | Massive Hepatic Necrosis | 4.9% |
| 251 | Nesidioblastosis | 4.9% |
| 252 | Variegate Porphyria | 4.9% |
| 253 | Acute intermittent porphyria | 4.9% |
| 254 | Porphyria Cutanea Tarda | 4.9% |
| 255 | Emphysematous Cholecystitis | 4.9% |
| 256 | Sphincter of Oddi Dysfunction | 4.9% |
| 257 | Hepatitis, Viral, Animal | 4.4% |
| 258 | Neoplasms, Radiation-Induced | 4.4% |
| 259 | Multiple Endocrine Neoplasia Type 1 | 4.4% |
| 260 | Adrenal Gland Neoplasms | 4.3% |
| 261 | Genital Neoplasms, Male | 4.3% |
| 262 | Uveal Neoplasms | 4.3% |
| 263 | Hepatitis E | 4.3% |
| 264 | Meningioma | 4.3% |
| 265 | Urologic Neoplasms | 4.3% |
| 266 | Hepatitis B | 4.3% |
| 267 | Hepatitis C | 4.3% |
| 268 | Hepatitis A | 4.3% |
| 269 | Sebaceous Gland Neoplasms | 4.3% |
| 270 | Spinal Neoplasms | 4.3% |
| 271 | Bone Marrow Neoplasms | 4.3% |
| 272 | Thymoma | 4.2% |
| 273 | Hepatic Encephalopathy | 4.2% |
| 274 | Zellweger Syndrome | 4.2% |
| 275 | Carcinoma 256, Walker | 4% |
| 276 | Hepatolenticular Degeneration | 3.9% |
| 277 | Tuberous Sclerosis | 3.9% |
| 278 | Carcinoma, Ehrlich Tumor | 3.9% |
| 279 | Dermoid Cyst | 3.9% |
| 280 | Carcinoma, Lewis Lung | 3.9% |
| 281 | Trophoblastic Neoplasms | 3.8% |
| 282 | Leukemia, Experimental | 3.8% |
| 283 | Leukoplakia, Oral | 3.7% |
| 284 | Paraneoplastic Cerebellar Degeneration | 3.7% |
| 285 | Nose Neoplasms | 3.7% |
| 286 | Acoustic Neuroma | 3.6% |
| 287 | Melanoma, Experimental | 3.5% |
| 288 | Palatal Neoplasms | 3.4% |
| 289 | Nephroblastoma | 3.4% |
| 290 | Pituitary Adenoma | 3.4% |
| 291 | Pituitary Neoplasms | 3.4% |
| 292 | Leukemia, Radiation-Induced | 3.4% |
| 293 | Erythroplasia | 3.4% |
| 294 | Follicular cyst | 3.4% |
| 295 | leukemia | 3.4% |
| 296 | Mucocele | 3.4% |
| 297 | Neoplasms, Germ Cell and Embryonal | 3.4% |
| 298 | Neoplasms, Glandular and Epithelial | 3.4% |
| 299 | Pilonidal Cyst | 3.4% |
| 300 | Thyroglossal Cyst | 3.4% |
| 301 | Synovial Cyst | 3.4% |
| 302 | Germ Cell Cancer | 3.4% |
| 303 | Aberrant Crypt Foci | 3.4% |
| 304 | Sarcoma, Experimental | 3.3% |
| 305 | Neuroectodermal Tumors | 3.3% |
| 306 | ovarian neoplasm | 3.3% |
| 307 | Meningeal Neoplasms | 3.3% |
| 308 | Retinoblastoma | 3.3% |
| 309 | Neoplasms, Neuroepithelial | 3.3% |
| 310 | Gliomatosis cerebri | 3.3% |
| 311 | Limbic Encephalitis | 3.3% |
| 312 | Lambert-Eaton Myasthenic Syndrome | 3% |
| 313 | Prolactinoma | 2.9% |
| 314 | Growth Hormone-Secreting Pituitary Adenoma | 2.9% |
| 315 | Ear Neoplasms | 2.9% |
| 316 | Eyelid Neoplasms | 2.9% |
| 317 | Lung Neoplasms | 2.9% |
| 318 | Pleural Neoplasms | 2.9% |
| 319 | Leydig Cell Tumor | 2.9% |
| 320 | Brain Neoplasms | 2.8% |
| 321 | Salivary Gland Neoplasms | 2.8% |
| 322 | Spinal Cord Neoplasms | 2.8% |
| 323 | Tongue Neoplasms | 2.8% |
| 324 | Leukoplakia | 2.8% |
| 325 | Lymphocele | 2.8% |
| 326 | Optic Nerve Glioma | 2.8% |
| 327 | melanoma | 2.8% |
| 328 | Uterine Neoplasms | 2.8% |
| 329 | Vaginal Neoplasms | 2.8% |
| 330 | Vulvar Neoplasms | 2.8% |
| 331 | Uterine Cancer | 2.8% |
| 332 | Fallopian Tube Neoplasms | 2.8% |
| 333 | Breast Cyst | 2.8% |
| 334 | Histiocytic Disorders, Malignant | 2.8% |
| 335 | Actinic keratosis | 2.8% |
| 336 | Mediastinal Cyst | 2.8% |
| 337 | Neoplasm Invasiveness | 2.8% |
| 338 | Neoplasm Metastasis | 2.8% |
| 339 | Neoplasm Recurrence, Local | 2.8% |
| 340 | Parovarian Cyst | 2.8% |
| 341 | Pericardial Cyst | 2.8% |
| 342 | Thymic Cyst | 2.8% |
| 343 | Carcinogenesis | 2.8% |
| 344 | Myxoid cyst | 2.8% |
| 345 | Metastasis | 2.8% |
| 346 | Carcinosarcoma | 2.7% |
| 347 | Hemangiosarcoma | 2.7% |
| 348 | Leukemia L1210 | 2.7% |
| 349 | Leukemia P388 | 2.7% |
| 350 | lymphangiosarcoma | 2.7% |
| 351 | Opsoclonus-Myoclonus Syndrome | 2.7% |
| 352 | Lymphomatoid Granulomatosis | 2.7% |
| 353 | Choriocarcinoma | 2.7% |
| 354 | granulosa cell tumor | 2.6% |
| 355 | Carcinoma, Ovarian Epithelial | 2.6% |
| 356 | Medulloblastoma | 2.6% |
| 357 | Pharyngeal Neoplasms | 2.5% |
| 358 | Rift Valley Fever | 2.5% |
| 359 | Central Nervous System Cysts | 2.5% |
| 360 | Penile Neoplasms | 2.5% |
| 361 | Prostatic Neoplasms | 2.5% |
| 362 | Composite Lymphoma | 2.5% |
| 363 | Myelitis, Transverse | 2.5% |
| 364 | Sarcoma 180 | 2.5% |
| 365 | Meningeal Carcinomatosis | 2.5% |
| 366 | Polycythemia Vera | 2.4% |
| 367 | Mesoblastic Nephroma | 2.4% |
| 368 | Basal Cell Nevus Syndrome | 2.4% |
| 369 | Lymphoma | 2.4% |
| 370 | Corpus Luteum Cyst | 2.4% |
| 371 | Ovarian Cysts | 2.4% |
| 372 | Leukemia, Plasma Cell | 2.3% |
| 373 | Adenoma, Acidophil | 2.3% |
| 374 | Ganglioneuroma | 2.3% |
| 375 | Glioma | 2.3% |
| 376 | Malignant Glioma | 2.3% |
| 377 | Laryngeal neoplasm | 2.3% |
| 378 | Bladder Neoplasm | 2.2% |
| 379 | Kidney Neoplasm | 2.2% |
| 380 | Ureteral Neoplasms | 2.2% |
| 381 | Urethral Neoplasms | 2.2% |
| 382 | Basal cell carcinoma | 2.2% |
| 383 | Carcinoma, Papillary | 2.2% |
| 384 | Squamous cell carcinoma | 2.2% |
| 385 | Chondrosarcoma | 2.2% |
| 386 | Craniopharyngioma | 2.2% |
| 387 | Cystadenoma | 2.2% |
| 388 | leiomyosarcoma | 2.2% |
| 389 | liposarcoma | 2.2% |
| 390 | Mesothelioma | 2.2% |
| 391 | synovial sarcoma | 2.2% |
| 392 | Neuroectodermal Tumor, Melanotic | 2.2% |
| 393 | Angiomyolipoma | 2.2% |
| 394 | Clear Cell Sarcoma of Soft Tissue | 2.2% |
| 395 | Alveolar Soft Part Sarcoma | 2.2% |
| 396 | Neuroendocrine Tumors | 2.2% |
| 397 | Sarcoma, Myeloid | 2.2% |
| 398 | Carcinoma, Basal Cell | 2.2% |
| 399 | Adrenocortical carcinoma | 2.2% |
| 400 | Bronchial Neoplasms | 2.1% |
| 401 | Multiple Pulmonary Nodules | 2.1% |
| 402 | Supratentorial Neoplasms | 2.1% |
| 403 | Carcinoid Tumor | 2.1% |
| 404 | Endometrial Neoplasms | 2.1% |
| 405 | Neurilemmoma | 2.1% |
| 406 | Hutchinson's Melanotic Freckle | 2.1% |
| 407 | Melanoma, Amelanotic | 2.1% |
| 408 | Adenoma | 2% |
| 409 | Ameloblastoma | 2% |
| 410 | Angiokeratoma | 2% |
| 411 | Carcinoma | 2% |
| 412 | Chordoma | 2% |
| 413 | Hemangioma | 2% |
| 414 | hemangiopericytoma | 2% |
| 415 | Lymphangioma | 2% |
| 416 | Mesenchymoma | 2% |
| 417 | Nevus | 2% |
| 418 | Teratoma | 2% |
| 419 | Hepatoblastoma | 2% |
| 420 | Mixed Tumor, Mullerian | 2% |
| 421 | Germinoma | 2% |
| 422 | Teratocarcinoma | 2% |
| 423 | Angiofibroma | 2% |
| 424 | Sarcoma | 2% |
| 425 | Epithelioma | 2% |
| 426 | Renal Cell Carcinoma | 1.9% |
| 427 | Papillary Renal Cell Carcinoma | 1.9% |
| 428 | Cystadenocarcinoma | 1.9% |
| 429 | Fibrosarcoma | 1.9% |
| 430 | Osteosarcoma | 1.9% |
| 431 | Mucoepidermoid Carcinoma | 1.9% |
| 432 | Hypopharyngeal Neoplasms | 1.9% |
| 433 | Pleural Effusion, Malignant | 1.9% |
| 434 | Hypopharyngeal Cancer | 1.9% |
| 435 | Astrocytoma | 1.9% |
| 436 | Ependymoma | 1.9% |
| 437 | oligodendroglioma | 1.9% |
| 438 | Ganglioglioma | 1.9% |
| 439 | gliosarcoma | 1.9% |
| 440 | Anaplastic astrocytoma | 1.9% |
| 441 | Anaplastic Oligodendroglioma | 1.9% |
| 442 | Parotid Neoplasms | 1.8% |
| 443 | Prostatic Neoplasms, Castration-Resistant | 1.8% |
| 444 | Endometrial Stromal Sarcoma | 1.8% |
| 445 | Nelson Syndrome | 1.8% |
| 446 | Adenofibroma | 1.8% |
| 447 | Fibroadenoma | 1.8% |
| 448 | Malignant Fibrous Histiocytoma | 1.8% |
| 449 | Denys-Drash Syndrome | 1.8% |
| 450 | Brain Stem Neoplasms | 1.7% |
| 451 | Malignant Carcinoid Syndrome | 1.7% |
| 452 | Nasopharyngeal carcinoma | 1.7% |
| 453 | Carcinoma, Endometrioid | 1.7% |
| 454 | Plasmacytoma | 1.7% |
| 455 | Malignant histiocytosis | 1.6% |
| 456 | Lymphatic Metastasis | 1.6% |
| 457 | Neoplasms, Unknown Primary | 1.6% |
| 458 | Leukemic Infiltration | 1.6% |
| 459 | Histiocytic sarcoma | 1.6% |
| 460 | Neoplasm Micrometastasis | 1.6% |
| 461 | Lymphangioleiomyomatosis | 1.6% |
| 462 | Bowen's Disease | 1.6% |
| 463 | Paraganglioma | 1.6% |
| 464 | Rhabdomyosarcoma | 1.6% |
| 465 | Giant Cell Tumor of Bone | 1.6% |
| 466 | Hydatidiform Mole | 1.6% |
| 467 | Glioblastoma | 1.6% |
| 468 | Neuroblastoma | 1.6% |
| 469 | Glioblastoma Multiforme | 1.6% |
| 470 | Choroid Plexus Papilloma | 1.6% |
| 471 | Tonsillar Neoplasms | 1.5% |
| 472 | Neurofibrosarcoma | 1.5% |
| 473 | Cerebellar Neoplasms | 1.5% |
| 474 | Ganglioneuroblastoma | 1.5% |
| 475 | Dermatofibrosarcoma | 1.5% |
| 476 | Dermatofibrosarcoma Protuberans | 1.5% |
| 477 | Nasopharyngeal Neoplasms | 1.5% |
| 478 | Hodgkin Disease | 1.4% |
| 479 | Lymphoma, Non-Hodgkin | 1.4% |
| 480 | Polycystic Ovary Syndrome | 1.4% |
| 481 | Xeroderma Pigmentosum | 1.4% |
| 482 | Carcinoid Heart Disease | 1.4% |
| 483 | Pheochromocytoma | 1.4% |
| 484 | Alveolar rhabdomyosarcoma | 1.4% |
| 485 | Paranasal Sinus Neoplasms | 1.4% |
| 486 | Adenocarcinoma | 1.3% |
| 487 | Carcinoma in Situ | 1.3% |
| 488 | Carcinoma, Transitional Cell | 1.3% |
| 489 | Phyllodes Tumor | 1.3% |
| 490 | Dysgerminoma | 1.3% |
| 491 | Hemangioendothelioma | 1.3% |
| 492 | Lipoma | 1.3% |
| 493 | Myoma | 1.3% |
| 494 | Myxoma | 1.3% |
| 495 | Neuroma | 1.3% |
| 496 | Papilloma | 1.3% |
| 497 | Pseudomyxoma Peritonei | 1.3% |
| 498 | Seminoma | 1.3% |
| 499 | Papillomatosis | 1.3% |
| 500 | Angiolipoma | 1.3% |
| 501 | Myelolipoma | 1.3% |
| 502 | Neoplasms, Bone Tissue | 1.3% |
| 503 | Neoplasms, Fibrous Tissue | 1.3% |
| 504 | Smooth Muscle Tumor | 1.3% |
| 505 | Adenomatosis, Pulmonary | 1.3% |
| 506 | Adenomatous Polyps | 1.3% |
| 507 | Carcinoma, Large Cell | 1.3% |
| 508 | Carcinoma, Small Cell | 1.3% |
| 509 | Desmoplastic Small Round Cell Tumor | 1.3% |
| 510 | Chondroma | 1.3% |
| 511 | Enchondroma | 1.3% |
| 512 | Primary amyloidosis | 1.2% |
| 513 | Maxillary Sinus Neoplasms | 1.1% |
| 514 | Leukemia, Myelomonocytic, Chronic | 1.1% |
| 515 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1.1% |
| 516 | Waldenstrom Macroglobulinemia | 1% |
| 517 | Multiple Myeloma | 1% |
| 518 | Adenoid Cystic Carcinoma | 1% |
| 519 | fibroma | 1% |
| 520 | Fibromatosis | 1% |
| 521 | Osteoblastoma | 1% |
| 522 | Osteoma | 1% |
| 523 | Rhabdomyoma | 1% |
| 524 | Chondromatosis | 1% |
| 525 | Adenocarcinoma, Clear Cell | 1% |
| 526 | Cholangiocarcinoma | 1% |
| 527 | Cervical Intraepithelial Neoplasia | 1% |
| 528 | Hemangioblastoma | 1% |
| 529 | Lymphoma, Extranodal NK-T-Cell | 1% |
| 530 | Mastocytosis | 1% |
| 531 | Sturge-Weber Syndrome | 1% |
| 532 | Cell Transformation, Viral | 0.9% |
| 533 | Hemangioma, Cavernous | 0.9% |
| 534 | Leukemia, T-Cell | 0.9% |
| 535 | Leukemia, B-Cell | 0.9% |
| 536 | neurofibroma | 0.9% |
| 537 | Lymphoma, Follicular | 0.9% |
| 538 | T-Cell Lymphoma | 0.9% |
| 539 | Mantle cell lymphoma | 0.9% |
| 540 | Mastocytoma | 0.8% |
| 541 | Fibromatosis, Aggressive | 0.8% |
| 542 | Fibromatosis, Abdominal | 0.8% |
| 543 | Klatskin Tumor | 0.8% |
| 544 | Mastocytosis, Systemic | 0.8% |
| 545 | Leukemia, Myeloid, Chronic-Phase | 0.8% |
| 546 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.7% |
| 547 | Leukemia, Large Granular Lymphocytic | 0.7% |
| 548 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.7% |
| 549 | Lymphoma, T-Cell, Cutaneous | 0.7% |
| 550 | Lymphoma, AIDS-Related | 0.7% |
| 551 | Enteropathy-Associated T-Cell Lymphoma | 0.7% |
| 552 | Primary Effusion Lymphoma | 0.7% |
| 553 | Dupuytren Contracture | 0.6% |
| 554 | Urticaria Pigmentosa | 0.6% |
| 555 | Mycosis Fungoides | 0.6% |
| 556 | Lymphomatoid Papulosis | 0.6% |
| 557 | Plasmablastic lymphoma | 0.6% |
| 558 | Burkitt Lymphoma | 0.5% |
| 559 | Sezary Syndrome | 0.5% |
| 560 | Radicular Cyst | 0.5% |
